← LifeStance Health Group, Inc. LFST
Market Price
$12.41
Market Cap
$4.67B
P/E Ratio
N/A
Revenue (FY 2026)
↓-66.5% YoY
$477.39M
3-Yr CAGR: -23.2%
Net Income
$9.66M
Net Margin: N/A
Free Cash Flow
↓-77.8% YoY
$24.41M
FCF Yield: 0.52%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
0.4%
ROA: 2.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (LFST)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2019 | $212.5M | — | $121.0M | — | — | — | — | $17.0M | $2.7M | — |
| FY 2020 | $279.0M | +31.3% | $83.0M | — | — | — | — | $8.7M | $4.2M | +53.8% |
| FY 2021 | $667.5M | +139.2% | $0.8M | $-307.2M | — | — | — | $9.4M | $-85.1M | -2,123.6% |
| FY 2022 | $859.5M | +28.8% | $237.0M | $-215.6M | +29.8% | — | — | $52.8M | $-26.5M | +68.9% |
| FY 2023 | $1,055.7M | +22.8% | $302.1M | $-186.3M | +13.6% | — | — | $-16.9M | $-57.4M | -116.9% |
| FY 2024 | $1,251.0M | +18.5% | $402.4M | $-57.4M | +69.2% | — | — | $107.3M | $85.7M | +249.3% |
| FY 2025 | $1,424.3M | +13.9% | $461.1M | $9.7M | +116.8% | — | — | $146.2M | $110.0M | +28.4% |
| FY 2026 | $477.4M | -66.5% | $162.1M | — | — | — | — | $25.8M | $24.4M | -77.8% |
Valuation
Market Price
$12.41
Market Cap
$4.67B
Enterprise Value
$4.53B
P/E Ratio
N/A
P/B Ratio
2.15
FCF Yield
0.52%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
33.95%
Operating Margin
-5.88%
Net Margin
N/A
Return on Equity (ROE)
0.44%
Return on Assets (ROA)
2.53%
Asset Turnover
1.25x
Revenue 3-Yr CAGR
-23.24%
Financial Health & Liquidity
Current Ratio
1.25
Cash Ratio
2.25
Debt / Equity
0.051
Debt / Assets
0.294
Cash & Equivalents
$248.64M
Total Debt
$112.42M
Book Value / Share
$5.77
Cash Flow Efficiency
Operating Cash Flow
$25.83M
Capital Expenditures (CapEx)
$1.42M
Free Cash Flow
$24.41M
OCF / Revenue
5.41%
FCF / Revenue
5.11%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$5.77
EPS YoY Growth
N/A
Balance Sheet (FY 2026)
Total Assets
$381.96M
Total Liabilities
$239.27M
Stockholders' Equity
$2.20B
Current Assets
$138.24M
Current Liabilities
$110.33M